On this World Alzheimer’s Day, on September 21, the fight against dementia is entering a more hopeful—but still uncertain—phase. The focus is shifting from simply managing memory loss to detecting Alzheimer’s earlier and slowing its progression.

World Alzheimer’s Month campaign theme is: ‘The Earlier You Know, The More You Can Do.’

For millions of families, Alzheimer’s begins quietly—a forgotten name, a missed appointment, a familiar road suddenly seeming unfamiliar. Early diagnosis gives patients and families more time to plan care, consider treatment and make important decisions.

One of the most significant developments is the rapid growth of research into disease-modifying treatments. According to the 2026 World Alzheimer Report, researchers are studying 158 drugs in 192 clinical trials. Although no Ayurvedic drugs are formally included, independent research and traditional herbs overlap significantly with the mechanisms being targeted. Studies are also shifting from amyloid targets to neuroinflammation and synaptic plasticity, which aligns closely with the modern pharmacological evaluation of traditional Medhya Rasayana (cognition-enhancing Ayurvedic herbs)

The scale of research reflects a growing belief that Alzheimer’s may be tackled before severe symptoms take hold.

Among the treatments attracting attention is trontinemab, an experimental drug designed to remove amyloid plaques associated with Alzheimer’s. It has moved into late-stage trials, but researchers stress that its safety and effectiveness still need to be established.

Diagnosis is also undergoing a quiet revolution. Scientists are looking for simpler ways to identify the disease before memory problems become obvious. One emerging approach examines how the brain processes competing sounds—sometimes described as a ‘brain hearing’ test. Such techniques could eventually help doctors identify people at higher risk much earlier.

New World Health Organization (WHO) guidelines say that up to 45% of dementia risk may be preventable or delayable, pointing to factors such as physical inactivity, smoking, social isolation, high blood pressure, diabetes and air pollution.

For India, where families often shoulder much of the responsibility for older relatives, the message is particularly relevant: dementia is not simply a problem of memory or ageing. It can affect independence, caregiving and household finances.

Alzheimer’s is yet to find a cure. The race is no longer only to treat dementia—it is increasingly to spot it sooner, slow it down, and give people more time.

References:

WHO; Alzheimer's Disease International (ADI); Alzheimer's Society; Dementia Connect